Bo Feng

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Ceyuan Ventures Investment Consulting (BE) Co. Ltd. is a Chinese venture capital firm which was founded by John S. Wadsworth, Jr., Chris Wadsworth, Feng Tao and Bo Feng in 2004. Based in Beijing with additional offices in Shanghai and San Francisco, Ceyuan Ventures aims to assist entrepreneurs in creating and building world-class businesses through their conviction, network of relationships and grass roots culture.

Ceyuan Ventures Investment Consulting (BE) Co. Ltd. is a Chinese venture capital firm which was founded by John S. Wadsworth, Jr., Chris Wadsworth, Feng Tao and Bo Feng in 2004. Based in Beijing with additional offices in Shanghai and San Francisco, Ceyuan Ventures aims to assist entrepreneurs in creating and building world-class businesses through their conviction, network of relationships and grass roots culture.

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Ceyuan Ventures Investment Consulting (BE) Co. Ltd. is a Chinese venture capital firm which was founded by John S. Wadsworth, Jr., Chris Wadsworth, Feng Tao and Bo Feng in 2004. Based in Beijing with additional offices in Shanghai and San Francisco, Ceyuan Ventures aims to assist entrepreneurs in creating and building world-class businesses through their conviction, network of relationships and grass roots culture.

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Ceyuan Ventures Investment Consulting (BE) Co. Ltd. is a Chinese venture capital firm which was founded by John S. Wadsworth, Jr., Chris Wadsworth, Feng Tao and Bo Feng in 2004. Based in Beijing with additional offices in Shanghai and San Francisco, Ceyuan Ventures aims to assist entrepreneurs in creating and building world-class businesses through their conviction, network of relationships and grass roots culture.

T2CN Holding Ltd. provides online sports and games. The company's products include Freestyle, Pangya Ii, Neo Steam, and Paipaijoy. The firm's partners include Hanbisoft, JCE, Sega, Nike, and Nokia. The company was established on October 10, 2004, and is headquartered in Shanghai, China.

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.